Behavior of unrepaired perimembranous ventricular septal defect in young adults

Veerle Soufflet1, Alexander Van de Bruaene, Els Troost

  • 1Cardiology and Pediatric Cardiology, University Hospitals Leuven, Belgium, Leuven.

Insights

Mid-term outcomes for adolescents and young adults with small, unclosed perimembranous ventricular septal defects (pmVSDs) show potential complications and spontaneous closures. Continuous monitoring is crucial for these congenital heart defect patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Adult Congenital Heart Disease

Background:

  • The population of adolescents and young adults with congenital heart defects (CHDs), including ventricular septal defects (VSDs), is growing.
  • Perimembranous VSDs (pmVSDs) are a common type of CHD, and their long-term outcomes in young adults are of increasing interest.

Purpose of the Study:

  • To evaluate the mid-term clinical, electrocardiographic, and echocardiographic outcomes of adolescents and young adults with small, unrepaired perimembranous VSDs.
  • To identify complications, spontaneous closure rates, and changes in cardiac structure and function over time.

Main Methods:

  • A retrospective analysis of patients aged 16 years or older with known unrepaired pmVSDs.
  • Comparison of baseline and latest follow-up data, including clinical status, ECG, and echocardiography.
  • Median follow-up duration of 6 years for 220 patients.

Main Results:

  • Two deaths (1%) occurred during follow-up; endocarditis in 8 patients (4%).
  • Fifteen patients (7%) required intervention, while 8 (4%) experienced spontaneous pmVSD closure.
  • Significant electrocardiographic changes (QRS morphology, sinus rhythm) and improved left ventricular function were observed.
  • Increased incidence of pulmonary arterial hypertension in patients with open pmVSDs (3% to 9%).

Conclusions:

  • Mid-term follow-up of small, unrepaired pmVSDs in young adults is not without risk, with potential for complications and interventions.
  • Spontaneous closure occurs in a subset of patients, alongside notable electrocardiographic and structural cardiac changes.
  • The clinical significance of observed changes warrants further investigation, emphasizing the need for ongoing monitoring.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...